Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Board Meeting On Wednesday, February 14, 2018

 This is to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, February 14, 2018, to consider and take on record, the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2017. In view of the consideration of above, the window closure for trading by designated persons as per Insider Trading Rules of the Company will be from Friday, February 02, 2018 to Friday, February 16, 2018 (both days inclusive).
29-01-2018

Sun Pharma says slump in US generic prices won't last long

 Sun Pharma chairman Israel Makov says he doesn't expect the slump in US generic prices that's roiling the global industry to last
25-01-2018
Bigul

Shareholding for the Period Ended December 31, 2017

 Sun Pharmaceutical Industries Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here
20-01-2018
Bigul

Press Release / Media Release

 We are pleased to enclose herewith our Press Release relating to settlement of patent litigation for generic Linzess in US, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you,
16-01-2018
Bigul

Statement Of Investor Grievance Report As Per Regulation 13(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended 31St December, 2017

 As required by Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below Statement of Investor Complaints for the quarter ended 31st December, 2017. Particulars Numbers Pending as on 1st October, 2017 0 Received during the quarter 0 Disposed of during the quarter 0 Unresolved as on 31st December, 2017 0
15-01-2018
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Valia
11-01-2018
Bigul

Updates

 Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
08-01-2018
Bigul

NPPA fixes retail prices of 14 formulations

 The formulations with fixed retail prices include Telmisartan and Chlorthalidone Tablet used in treating high blood pressure marketed by Sun Pharma
03-01-2018
Bigul

Specialty drug boost for Sun Pharma

 Valuations, however, already factor in some of the positives
28-12-2017
Bigul

Sun Pharma's specialty business gets USFDA boost

 Stock gained over 6% as FDA accepts application for new ophthalmic drug
27-12-2017
Next Page
Close

Let's Open Free Demat Account